Literature DB >> 16247324

Hepatosplanchnic circulatory dysfunction in acute hepatic infection: the case of dengue hemorrhagic fever.

Apichai Khongphatthanayothin1, Pornthep Lertsapcharoen, Pentip Supachokchaiwattana, Patcharapa Satupan, Kriangsak Thongchaiprasit, Yong Poovorawan, Chule Thisyakorn.   

Abstract

The mechanism of shock in patients with dengue hemorrhagic fever (DHF) has not yet been fully understood. In this study, we investigated the possibility of splanchnic venous pooling as a contributor for circulatory dysfunction in these patients. Ultrasonographic studies of portal vein and inferior vena cava were done in 45 patients with serologically or PCR-confirmed diagnosis of dengue virus infection. The size of portal vein and inferior vena cava, mean blood flow velocity in the right portal vein, and modified portal vein congestion index were compared between patients with dengue fever (DF, n = 20), DHF without shock (n = 14), and dengue shock syndrome (DSS, n = 11) during the toxic stage, convalescent stage, and at follow-up. The portal vein was significantly more dilated in patients with shock (DSS) than DHF without shock and than DF during the toxic and convalescent stages (P < 0.05), but not at follow-up. The change in the size of inferior vena cava followed the opposite trend (not statistically significant). Portal vein blood flow velocity was lower and congestion index was higher in shock cases (DSS) than DHF without shock and than DF at toxic and convalescent stages (P < 0.01). The differences disappeared at follow-up. Hepatosplanchnic venous pooling and/or dysfunction occur and correlate with the severity of circulatory derangement and shock in patients with DHF. The cause(s) and significance of hepatosplanchnic circulatory dysfunction in DHF and possibly other viral hepatic diseases deserve further study.

Entities:  

Mesh:

Year:  2005        PMID: 16247324     DOI: 10.1097/01.shk.0000180981.70870.8c

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro.

Authors:  Shanley Blackley; Zhihua Kou; Huiyuan Chen; Matthew Quinn; Robert C Rose; Jacob J Schlesinger; Myra Coppage; Xia Jin
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 2.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

3.  Evaluation of Cardiac Involvement in Children with Dengue by Serial Echocardiographic Studies.

Authors:  Tawatchai Kirawittaya; In-Kyu Yoon; Sineewanlaya Wichit; Sharone Green; Francis A Ennis; Robert V Gibbons; Stephen J Thomas; Alan L Rothman; Siripen Kalayanarooj; Anon Srikiatkhachorn
Journal:  PLoS Negl Trop Dis       Date:  2015-07-30

4.  Possible cause of liver failure in patient with dengue shock syndrome.

Authors:  Apichai Khongphatthanayothin; Atchara Mahayosnond; Yong Poovorawan
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

5.  Extensive haemorrhagic necrosis of liver is an unpredictable fatal complication in dengue infection: a postmortem study.

Authors:  S A M Kularatne; I V B Imbulpitiya; R A Abeysekera; R N Waduge; R P V J Rajapakse; K G A D Weerakoon
Journal:  BMC Infect Dis       Date:  2014-03-14       Impact factor: 3.090

6.  Crocetin Improves Dengue Virus-Induced Liver Injury.

Authors:  Gopinathan Pillai Sreekanth; Aporn Chuncharunee; Pa-Thai Yenchitsomanus; Thawornchai Limjindaporn
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.